Publicação

Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma

Ver documento

Detalhes bibliográficos
Resumo:Pancreatic ductal adenocarcinoma (PDAC) has high mortality rates, poor prognosis, and currently limited effective treatments. Natural killer (NK) cells from tumor-infiltrating lymphocytes (TIL) show promise for cancer treatment due to their ability to migrate to the tumor microenvironment (TME) and safe profile. However, expanding functional patient-derived NK cells remains challenging. Here, we cultured, expanded, and characterized TIL-NK cells isolated from central and peripheral tumor regions from PDAC. Ex vivo patient-derived PBMCs and TIL were cultured under IL-2, IL-15, and IL-12 stimulation. Phenotypical and functional NK cell characterization was assessed at the time of surgery and after 12 days of culture evaluating immunophenotype, expansion rate, and activation. A distinct distribution of NK cell infiltration was observed within the TME, with higher NK cell numbers in the periphery of the tumor compared to the central area. Most NK cells displayed a cytotoxic phenotype (CD56+ CD16+). Compared to PBMCs, TIL-NK cells expressed lower activation markers but superior tumor infiltration and expansion rates, particularly those isolated from the central regions. Notably, cytokine stimulation improved patient-derived NK cell activation and cytotoxic profile. This pilot study provides preliminary but critical insights regarding TIL-NK cells from PDAC patients, laying groundwork for developing NK cell-based immunotherapies for solid tumors.
Autores principais:Maia, Andreia
Outros Autores:Calá, Hasti; de Sousa, Eric; Lérias, Joana R.; Gorgulho, Carolina M.; António, Patrícia A.; Kamiki, Jéssica; Ligeiro, Dário; Borrego, Luis M.; Maeurer, Markus; Castillo-Martin, Mireia
Assunto:adoptive cell therapy natural killer cells NK-TIL pancreatic ductal adenocarcinoma solid tumours TIL therapy tumor-infiltrating lymphocytes General Biochemistry,Genetics and Molecular Biology SDG 3 - Good Health and Well-being
Ano:2026
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
_version_ 1866752610228240384
author Maia, Andreia
author2 Calá, Hasti
de Sousa, Eric
Lérias, Joana R.
Gorgulho, Carolina M.
António, Patrícia A.
Kamiki, Jéssica
Ligeiro, Dário
Borrego, Luis M.
Maeurer, Markus
Castillo-Martin, Mireia
author2_role author
author
author
author
author
author
author
author
author
author
author_facet Maia, Andreia
Calá, Hasti
de Sousa, Eric
Lérias, Joana R.
Gorgulho, Carolina M.
António, Patrícia A.
Kamiki, Jéssica
Ligeiro, Dário
Borrego, Luis M.
Maeurer, Markus
Castillo-Martin, Mireia
author_role author
contributor_name_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
MDPI - Multidisciplinary Digital Publishing Institute
RUN
country_str PT
creators_json_txt [{\"Person.name\":\"Maia, Andreia\"},{\"Person.name\":\"Calá, Hasti\"},{\"Person.name\":\"de Sousa, Eric\"},{\"Person.name\":\"Lérias, Joana R.\"},{\"Person.name\":\"Gorgulho, Carolina M.\"},{\"Person.name\":\"António, Patrícia A.\"},{\"Person.name\":\"Kamiki, Jéssica\"},{\"Person.name\":\"Ligeiro, Dário\"},{\"Person.name\":\"Borrego, Luis M.\"},{\"Person.name\":\"Maeurer, Markus\"},{\"Person.name\":\"Castillo-Martin, Mireia\"}]
datacite.contributors.contributor.contributorName.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
MDPI - Multidisciplinary Digital Publishing Institute
RUN
datacite.creators.creator.creatorName.fl_str_mv Maia, Andreia
Calá, Hasti
de Sousa, Eric
Lérias, Joana R.
Gorgulho, Carolina M.
António, Patrícia A.
Kamiki, Jéssica
Ligeiro, Dário
Borrego, Luis M.
Maeurer, Markus
Castillo-Martin, Mireia
datacite.date.Accepted.fl_str_mv 2026-05-01T00:00:00Z
datacite.date.available.fl_str_mv 2026-05-22T15:07:01Z
datacite.date.embargoed.fl_str_mv 2026-05-22T15:07:01Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv adoptive cell therapy
natural killer cells
NK-TIL
pancreatic ductal adenocarcinoma
solid tumours
TIL therapy
tumor-infiltrating lymphocytes
General Biochemistry,Genetics and Molecular Biology
SDG 3 - Good Health and Well-being
datacite.titles.title.fl_str_mv Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
MDPI - Multidisciplinary Digital Publishing Institute
RUN
dc.creator.none.fl_str_mv Maia, Andreia
Calá, Hasti
de Sousa, Eric
Lérias, Joana R.
Gorgulho, Carolina M.
António, Patrícia A.
Kamiki, Jéssica
Ligeiro, Dário
Borrego, Luis M.
Maeurer, Markus
Castillo-Martin, Mireia
dc.date.Accepted.fl_str_mv 2026-05-01T00:00:00Z
dc.date.available.fl_str_mv 2026-05-22T15:07:01Z
dc.date.embargoed.fl_str_mv 2026-05-22T15:07:01Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10362/203332
dc.language.none.fl_str_mv eng
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv adoptive cell therapy
natural killer cells
NK-TIL
pancreatic ductal adenocarcinoma
solid tumours
TIL therapy
tumor-infiltrating lymphocytes
General Biochemistry,Genetics and Molecular Biology
SDG 3 - Good Health and Well-being
dc.title.fl_str_mv Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description Pancreatic ductal adenocarcinoma (PDAC) has high mortality rates, poor prognosis, and currently limited effective treatments. Natural killer (NK) cells from tumor-infiltrating lymphocytes (TIL) show promise for cancer treatment due to their ability to migrate to the tumor microenvironment (TME) and safe profile. However, expanding functional patient-derived NK cells remains challenging. Here, we cultured, expanded, and characterized TIL-NK cells isolated from central and peripheral tumor regions from PDAC. Ex vivo patient-derived PBMCs and TIL were cultured under IL-2, IL-15, and IL-12 stimulation. Phenotypical and functional NK cell characterization was assessed at the time of surgery and after 12 days of culture evaluating immunophenotype, expansion rate, and activation. A distinct distribution of NK cell infiltration was observed within the TME, with higher NK cell numbers in the periphery of the tumor compared to the central area. Most NK cells displayed a cytotoxic phenotype (CD56+ CD16+). Compared to PBMCs, TIL-NK cells expressed lower activation markers but superior tumor infiltration and expansion rates, particularly those isolated from the central regions. Notably, cytokine stimulation improved patient-derived NK cell activation and cytotoxic profile. This pilot study provides preliminary but critical insights regarding TIL-NK cells from PDAC patients, laying groundwork for developing NK cell-based immunotherapies for solid tumors.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://run.unl.pt/bitstreams/bead53bd-0292-4d20-9f11-0650f9f04126/download
id run_ef82dd287d0da2c2f38c45a8b19a04ca
identifier.url.fl_str_mv http://hdl.handle.net/10362/203332
instacron_str unl
institution Universidade Nova de Lisboa
instname_str Universidade Nova de Lisboa
language eng
network_acronym_str run
network_name_str Repositório Institucional da UNL
oai_identifier_str oai:run.unl.pt:10362/203332
organization_str_mv urn:organizationAcronym:unl
person_str_mv Maia, Andreia
Calá, Hasti
de Sousa, Eric
Lérias, Joana R.
Gorgulho, Carolina M.
António, Patrícia A.
Kamiki, Jéssica
Ligeiro, Dário
Borrego, Luis M.
Maeurer, Markus
Castillo-Martin, Mireia
publishDate 2026
reponame_str Repositório Institucional da UNL
repository_id_str urn:repositoryAcronym:run
service_str_mv urn:repositoryAcronym:run
spelling engenPancreatic ductal adenocarcinoma (PDAC) has high mortality rates, poor prognosis, and currently limited effective treatments. Natural killer (NK) cells from tumor-infiltrating lymphocytes (TIL) show promise for cancer treatment due to their ability to migrate to the tumor microenvironment (TME) and safe profile. However, expanding functional patient-derived NK cells remains challenging. Here, we cultured, expanded, and characterized TIL-NK cells isolated from central and peripheral tumor regions from PDAC. Ex vivo patient-derived PBMCs and TIL were cultured under IL-2, IL-15, and IL-12 stimulation. Phenotypical and functional NK cell characterization was assessed at the time of surgery and after 12 days of culture evaluating immunophenotype, expansion rate, and activation. A distinct distribution of NK cell infiltration was observed within the TME, with higher NK cell numbers in the periphery of the tumor compared to the central area. Most NK cells displayed a cytotoxic phenotype (CD56+ CD16+). Compared to PBMCs, TIL-NK cells expressed lower activation markers but superior tumor infiltration and expansion rates, particularly those isolated from the central regions. Notably, cytokine stimulation improved patient-derived NK cell activation and cytotoxic profile. This pilot study provides preliminary but critical insights regarding TIL-NK cells from PDAC patients, laying groundwork for developing NK cell-based immunotherapies for solid tumors.application/pdfenTumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal AdenocarcinomaMaia, AndreiaCalá, Hastide Sousa, EricLérias, Joana R.Gorgulho, Carolina M.António, Patrícia A.Kamiki, JéssicaLigeiro, DárioBorrego, Luis M.Maeurer, MarkusCastillo-Martin, MireiaNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)MDPI - Multidisciplinary Digital Publishing InstituteHostingInstitutionOrganizationalRUNe-mailmailto:run@unl.ptrun@unl.ptISSNIsPartOf2073-4409URNIsPartOfPURE: 163205937URNIsPartOfPURE UUID: ede5fe26-6f1e-4dcd-870d-3e1a42cb0d25URNIsPartOfScopus: 105038401277URNIsPartOfORCID: /0000-0003-4708-438X/work/215513568DOIIsPartOf10.3390/cells150907972026-05-22T15:07:01Z2026-052026-05-01T00:00:00ZHandlehttp://hdl.handle.net/10362/203332http://purl.org/coar/access_right/c_abf2open accessadoptive cell therapynatural killer cellsNK-TILpancreatic ductal adenocarcinomasolid tumoursTIL therapytumor-infiltrating lymphocytesGeneral Biochemistry,Genetics and Molecular BiologySDG 3 - Good Health and Well-being3656918 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal articlehttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://run.unl.pt/bitstreams/bead53bd-0292-4d20-9f11-0650f9f04126/download
spellingShingle Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma
Maia, Andreia
adoptive cell therapy
natural killer cells
NK-TIL
pancreatic ductal adenocarcinoma
solid tumours
TIL therapy
tumor-infiltrating lymphocytes
General Biochemistry,Genetics and Molecular Biology
SDG 3 - Good Health and Well-being
status SINGLETON
subject.fl_str_mv adoptive cell therapy
natural killer cells
NK-TIL
pancreatic ductal adenocarcinoma
solid tumours
TIL therapy
tumor-infiltrating lymphocytes
General Biochemistry,Genetics and Molecular Biology
SDG 3 - Good Health and Well-being
title Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma
title_full Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma
title_fullStr Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma
title_full_unstemmed Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma
title_short Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma
title_sort Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma
topic adoptive cell therapy
natural killer cells
NK-TIL
pancreatic ductal adenocarcinoma
solid tumours
TIL therapy
tumor-infiltrating lymphocytes
General Biochemistry,Genetics and Molecular Biology
SDG 3 - Good Health and Well-being
topic_facet adoptive cell therapy
natural killer cells
NK-TIL
pancreatic ductal adenocarcinoma
solid tumours
TIL therapy
tumor-infiltrating lymphocytes
General Biochemistry,Genetics and Molecular Biology
SDG 3 - Good Health and Well-being
url http://hdl.handle.net/10362/203332
visible 1